#CVM #NYSE! Cel-Sci is making waves proving its potential to revolutionize cancer treatment! Wow!

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Exciting times for #CVM #NYSE! Cel-Sci is making waves with its innovative Multikine #immunotherapy, showing promising results in pre-surgical #tumor #elimination and #regression in just 3 weeks according to their latest Q1 2025 financials. With a confirmatory Phase 3 study underway and a strong push toward #FDA approval, this #biotech gem is proving its potential to revolutionize #cancer treatment. $CVM is definitely one to watch as they continue to advance cutting-edge #science for patients in need!"


CEL-SCI Corporation (#NYSE American: #CVM), a #biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer, #autoimmune and infectious #diseases. The Company's core capabilities include: #drug discovery, research, development and manufacturing of complex #biological substances. Non toxic cancer drug.

#CVM "Big moves brewing at #CelSci #CVM on the #NYSE! #FDA greenlights their #Multikine study for head & neck cancer—kicking off Q1 2025. is this the #biotech sleeper ready to explode? Don’t sleep on it! #CVM #NYSE Cel-Sci Corp.

Website
https://cel-sci.com

YouTube
https://m.youtube.com/@CEL-SCI?

Yahoo finance
https://finance.yahoo.com/quote/CVM/

#biotech #biotechnology #Cancer #WallStreet #FDA #investing #stockmarket #Trump
#investing #biotech"
#podcast
#biotechboom
Category
Oncology
Be the first to comment

Up Next